Clinical Trial Update: Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing effectiveness and safety of desloratadine syrup in children with atopic dermatitis and dermatitis conditions; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Dermatitis

Drugs mentioned

• Aerius (cetirizine)
• Desloratadine (desloratadine)

Snippet

Sponsor: Organon and Co | Conditions: Dermatitis, Atopic | Phase 3 | Status: COMPLETED